Risk scores are statistical indicators based on prescribing patterns compared to specialty peers. They are NOT allegations of fraud, misconduct, or improper care. Many legitimate medical reasons can explain outlier prescribing.
Read our methodology →Risk Flags
Risk indicators are statistical patterns, not allegations. Learn more
17,570
Total Claims
$1.2M
Drug Cost
883
Beneficiaries
$1,308
Cost/Patient
Risk Score Breakdown 13/100
Score components are additive. Read full methodology
Peer Comparison vs. 106,889 Family Practice providers
+68%
Opioid rate vs peers
4.3% vs 2.6% avg
+23%
Cost per patient vs peers
$1,308 vs $1,068 avg
+21%
Brand preference vs peers
10.9% vs 9.0% avg
⚠️ Opioid + Benzodiazepine Co-Prescriber
This provider prescribes both opioids and benzodiazepines. The FDA has issued a Black Box Warning about the life-threatening risks of concurrent use.
Opioid Prescribing
4.3%
Opioid Rate
759
Opioid Claims
$14K
Opioid Cost
—
Long-Acting Rate
Brand vs Generic
Brand: 1,900 claims · $927K
Generic: 15,608 claims · $225K
Top Prescribed Drugs
| Drug (Generic) | Claims | Cost |
|---|---|---|
| Semaglutide | 60 | $104K |
| Apixaban | 122 | $98K |
| Sitagliptin Phosphate | 66 | $62K |
| Empagliflozin | 43 | $62K |
| Rivaroxaban | 58 | $54K |
| Tirzepatide | 30 | $35K |
| Evolocumab | 42 | $35K |
| Budesonide/Formoterol Fumarate | 64 | $29K |
| Insulin Detemir | 23 | $21K |
| Sitagliptin Phos/Metformin Hcl | 21 | $19K |
| Insulin Aspart | 23 | $19K |
| Linagliptin | 24 | $18K |
| Insulin Glargine,hum.Rec.Anlog | 25 | $18K |
| Insulin Glargine,hum.Rec.Anlog | 13 | $17K |
| Rsvpref3 Antigen/As01e/Pf | 50 | $16K |
Prescribing Profile
Patient Profile
74
Avg Age
60%
Female
1.17
Avg Risk Score
Explore More
Data from CMS Medicare Part D Prescriber Public Use File, 2023. Risk scores are statistical indicators, not allegations.Methodology · About